Valeo Financial Advisors LLC grew its position in shares of Clorox Co (NYSE:CLX) by 100.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,000 shares of the company’s stock after purchasing an additional 500 shares during the period. Valeo Financial Advisors LLC’s holdings in Clorox were worth $154,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Savior LLC purchased a new position in Clorox in the 4th quarter valued at about $31,000. Strategic Blueprint LLC purchased a new stake in shares of Clorox during the third quarter worth about $37,000. Transamerica Financial Advisors Inc. purchased a new stake in shares of Clorox during the second quarter worth about $41,000. Usca Ria LLC acquired a new position in shares of Clorox in the third quarter worth about $41,000. Finally, Wealthcare Advisory Partners LLC lifted its stake in shares of Clorox by 48.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 307 shares of the company’s stock worth $47,000 after acquiring an additional 100 shares in the last quarter. 77.94% of the stock is currently owned by institutional investors and hedge funds.
Shares of CLX stock opened at $158.28 on Monday. The company has a market cap of $19.86 billion, a P/E ratio of 25.08, a PEG ratio of 5.09 and a beta of 0.39. The business has a 50 day moving average of $153.75 and a two-hundred day moving average of $153.99. Clorox Co has a 52 week low of $143.58 and a 52 week high of $166.90. The company has a quick ratio of 0.52, a current ratio of 0.87 and a debt-to-equity ratio of 4.69.
Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, October 31st. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.05. The business had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Clorox had a return on equity of 123.56% and a net margin of 13.20%. The business’s quarterly revenue was down 3.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.62 EPS. Analysts expect that Clorox Co will post 6.14 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.06 per share. The ex-dividend date of this dividend is Tuesday, January 28th. This represents a $4.24 dividend on an annualized basis and a yield of 2.68%. Clorox’s payout ratio is currently 67.09%.
In other Clorox news, SVP Denise Garner sold 725 shares of the firm’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $146.34, for a total value of $106,096.50. Following the sale, the senior vice president now directly owns 5,805 shares in the company, valued at $849,503.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Andrew J. Mowery sold 5,648 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the transaction, the senior vice president now directly owns 15,920 shares of the company’s stock, valued at approximately $2,328,936.80. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.
A number of equities research analysts have weighed in on CLX shares. Citigroup lowered their price objective on Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a research note on Thursday, October 3rd. Bank of America reduced their target price on Clorox from $165.00 to $160.00 and set a “neutral” rating for the company in a research note on Thursday, October 3rd. Deutsche Bank upped their price target on shares of Clorox from $145.00 to $147.00 and gave the company a “hold” rating in a report on Thursday, December 12th. Cfra downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. Finally, Wells Fargo & Co reissued a “hold” rating and issued a $150.00 target price on shares of Clorox in a research report on Wednesday, October 2nd. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $152.17.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: New Google Finance Tool and Screening Stocks
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.